Pfizer raises forecast as cancer, blood thinner drugs cushion COVID-19 blow

Pfizer Inc beat analysts' estimates for secondquarter profit on Tuesday and raised its fullyear earnings forecast, as demand for cancer drug Ibrance and blood thinner Eliquis offset lower uptake of other treatments in the COVID19 pandemic.

from Top Business News- News18.com https://ift.tt/3hNwx8V

• Tweet
• Share
• Share
• Share
• Share